Colorectal cancer mass screening, Tunisia 2019. Evaluation of a pilot program in the Tunis region (Tunisia, 2019)
##plugins.themes.academic_pro.article.main##
Abstract
Introduction: Colorectal cancer (CRC) is a real public health issue in Tunisia. A screening program based on fecal immunological occult blood test, followed in case of a positive test by colonoscopy, was launched in Tunis region in 2016. We aimed to evaluate this screening program in order to make recommendations for a better implementation of this program in years to come.
Methods: A mixed approach has been adopted with a quantitative component based on the production of indicators related to activity, monitoring and screening quality; and a qualitative component conducted through focus groups with frontline health care professionals (HCP) and individual interviews with those lost to follow-up after a positive screening test. SWOT analysis was then performed in order to assess main strengths, weaknesses, opportunities and threats of the program.
Results: This study showed a coverage rate of 41.2% [40.5-41.8] for population consulting the first line of care, and an effective participation rate estimated at 23.1% [22.6-23.6]. Out of 5856 tests performed, 6% (n=352) were non-treatable and 6.7 % (n=390) were positive. Only 18.6% (n=72) of those tested positive had undergone colonoscopy. A total of 26 polyps, 03 cases of cancer and 04 cases of dysplasia were recorded. SWOT analysis pointed out that the variable adherence of HCP, lack of awareness of general population regarding CRC screening, the non-acceptability of colonoscopy without sedation with a problem of affordability for its realization in the private sector, and long appointments delays in public sector, were main weaknesses and of this program.
Conclusion: This evaluation underlined certain strengths regarding the program implementation and revealed, in return, several shortcomings which certainly impair the program’s effectiveness and efficiency. The involvement of the national health insurance fund in CRC screening tests and colonoscopies reimbursement, as well as the establishment of a performance-based payment modality for HCP, constitute main key pillars to reach success and sustainability for any CCR mass screening program in Tunisia.
Keywords:
Colorectal Neoplasms - Mass Screening - Program Evaluation - Qualitative Research - Focus Groups - Public health - Tunisia##plugins.themes.academic_pro.article.details##
References
- REFERENCES 1. The Global Cancer Observatory - May 2019. https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf. 2. Navarro M, Nicolas A, Ferrandez A, Lanas A. Colorectal cancer population screening programs worldwide in 2016: An update. World J Gastroenterol. 2017; 23(20):3632. 3. The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary prevention. Br J Cancer. 2018, 119(7):785-92. 4. Maida M, Macaluso FS, Ianiro G, Mangiola F, Sinagra E, Hold G, et al. Screening of colorectal cancer: present and future. Expert Rev Anticancer Ther. 2017; 17(12):1131-46. 5. Khiari H, Ayoub HWB, Khadhra HB, Hsairi M. Colorectal Cancer Incidence Trend and Projections in Tunisia (1994 - 2024). Asian Pac J Cancer Prev. 2017; 18(10):2733. 6. Ministère de santé publique. Plan pour la lutte contre le cancer en Tunisie (2015-2019). Tunis: MSP; 2015. 7. Institut National de Veille Sanitaire. Evaluation du programme de dépistage du cancer colorectal: indicateurs d'évaluation. Paris: INVS; 2015. 8. Institut National de la Statistique. Recensement général de la population et de l'habitat 2014. Tunis: INS; 2015. 9. Institut National du Cancer. Les niveaux de risque de cancer colorectal. Paris: INC; 2015. 10. Ministère de santé publique. Rapport de l'enquête nationale Tunisian Health Examination Survey. Tunis: MSP; 274-276, 2015. 11. Costantino C, Mazzucco W, Marotta C, Saporito L, Bono S, Fiorino G et al. Methodological issues in a cross-sectional survey on cervical cancer screening using telephone interviews in Sicily (Italy): a SWOT analysis. J International Med Research 2019; 47(10), 5174-84. 12. Cadiz F, Kuerer H, Puga J, Camacho J, Cunill E, Arun B et al. Establishing a program for individuals at high risk for breast cancer. J Cancer. 2013; 4(5), p433. 13. Dorothy L, Messina R, Mary F, Cavanagh M, Chen J. A provider intervention to improve colorectal cancer screening in county health centers. Med Care. 2008, S109-S116. 14. Cossu G, Saba L, Minerba L, Mascalchi M. Colorectal Cancer screening: the role of psychological, social and background factors in decision-making process. Clin practice Epidemiol Mental Health 2018; 14, 63. 15. Fujiwara M, Inagaki M, Nakaya N, Fujimori M, Higuchi Y, Kakeda K et al. Association between serious psychological distress and nonparticipation in cancer screening and the modifying effect of socioeconomic status: Analysis of anonymized data from a national crosss ectional survey in Japan. Cancer. 2018; 124(3), 555-62. 16. Hsairi M, Mehdi F, Bellaaj R, Kassis M. La stratégie de dépistage dans les pays du Grand Maghreb: État des lieux et perspectives. Tunis Med 2018; 96 (10): 688 - 95. 17. Belhadj A, Boublenza L, Sidaoui A, Chiah B, Benhamou A., Boulenouar F et al. Women's knowledge about cervical cancer and their pap smear test participation in Algeria. J Med Health Research 2017. 65-71. 18. Lamtali S, Loukid M. Knowledge of cervical cancer and uptake of screening test among women in the Region of Marrakesh, Morocco. SN Comprehensive Clin Med. 2019; 1(12), 1023-28. 19. Sano Y, Byeon J, Li XB, Wong M, Chiu HM, Utsumi T et al. Colorectal cancer screening of the general population in East Asia. Dig Endosc. 2016; 28(3), 243-9. 20. Hussain I, Majeed A, Rasool M, Hussain M, Imran I, Ullah M et al. Knowledge, attitude, preventive practices and perceived barriers to screening about colorectal cancer among university students of newly merged district, Kpk, Pakistan-A cross-sectional study. J Oncol Pharm Pract. 2020; 1-8. 21. Zhu MM, Xu XT, Nie F, Tong JL, Xiao SD, Ran ZH. Comparison of immunochemical and guaiac-based fecal occult blood test in screening and surveillance for advanced colorectal neoplasms: A meta-analysis: Screening for colorectal cancer. J Dig Dis. 2010; 11(3):148-60. 22. Tinmouth J, Lansdorp-Vogelaar I, Allison JE. Faecal immunochemical tests versus guaiac fecal occult blood tests: what clinicians and colorectal cancer screening program organizers need to know. Gut. 2015; 64(8):1327-37. 23. Denis B, Guittet L. Dépistage du cancer colorectal par test immunologique quantitatif de recherche de sang occulte dans les selles: une révolution? Hepato-Gastro Oncol Dig. 2015; 22(2):119-29. 24. Doubeni A, Gabler N, Wheeler C, McCarthy A, Castle E, Halm A et al. Timely follow up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium. CA Cancer J Clin. 2018; 68(3), 199-216. 25. Meester R, Zauber G, Doubeni A, Jensen C, Quinn V, Helfand M et al. Consequences of increasing time to colonoscopy examination after positive result from fecal colorectal cancer screening test. Clin Gastroenterol Hepatol 2016; 14(10), 1445-51. 26. Cheng S, Li MC, Chia S, Huan K C, Chiu T, Chiu H et al. Factors affecting compliance with confirmatory colonoscopy after a positive fecal immunochemical test in a national colorectal screening program. Cancer. 2018; 124(5), 907-15. 27. Hadjipetrou A, Anyfantakis D, Galanakis C, Kastanakis M, Kastanakis S. Colorectal cancer, screening and primary care: a mini literature review. World J Gastroenterol. 2017; 23(33), 6049. 28. Selby K, Baumgartner C, Levin R, Doubeni C, Zauber A, Corley A et al. Interventions to improve follow-up of positive results on fecal blood tests: a systematic review. Annals Internal Med 2017; 167(8), 565-75. 29. Muliira J, D'Souza M. Effectiveness of patient navigator interventions on uptake of colorectal cancer screening in primary care settings. Japan J Nursing Science 2016; 13(2), 205-19. 30. Genoff M, Zaballa A, Gany F, Gonzalez J, Ramirez J, Jewell S et al. Navigating language barriers: a systematic review of patient navigators' impact on cancer screening for limited English proficient patients. J General internal Med. 2016; 31(4), 426-34. 31. Rizzello A, Caridà R, Trotta A, Ferraro G, Carè R. The use of payment by results in healthcare: A review and proposal. In Social Impact Investing beyond the SIB; Palgrave Macmillan: London, UK, 2018; p. 69-113. 32. Gourieux B, Duvernoy T, Tissier F, Garassus P. Les réformes en faveur du paiement à la qualité en Europe: état des lieux, analyse et propositions. Journal de gestion et d'economie medicales. 2017 ; 35(6), 287-304. 33. El Khider A, Imichoui H. La régionalisation, nouveau mode de gouvernance du système de santé: état des lieux pour le cas du Maroc. Eur Sci J. 2020 ; Vol16, 154-71. 34. Hassani K, El Moussali M. Le New Public Management: quels enjeux pour le système de santé publique au Maroc? Int J Man Sci. 2020 ; 3(1).